资源说明:[ADDIS 1.x] Aggregate Data Drug Information System
ADDIS - Aggregate Data Drug Information System ============================================== [![Build Status](https://travis-ci.org/drugis/addis.png)](https://travis-ci.org/drugis/addis) [ADDIS][1] is a software developed within the Dutch [Escher-project][2] for managing and analyzing clinical trial information. ADDIS comes with two built-in examples: * An anti-depressants example modeled on the paper: [Hansen et al., Annals of internal medicine, 143(6): 415-426, 2005][3]. All data was extracted by us from the original papers. * A hypertension example based on the EMA EPAR evaluating Edarbi. The data were imported from ClinicalTrials.gov, with manual corrections where needed. Requirements ------------ ADDIS is made in [Java][4], and requires Java 7 (JRE 1.7) or newer. Most modern operating systems ship with a suitable JRE. Versions -------- 1.16.8: Bugfixes for export to ADDIS 2. 1.16.7: Add export to ADDIS 2. Require Java 7. 1.16.6: Bugfix release. 1.16.5: Bugfix release. 1.16.4: JSON export of benefit-risk models; bugfixes. 1.16.3: Bugfix release. 1.16.2: Bugfix release. 1.16.1: Updated to GeMTC 0.14.1 for bugfixes and minor improvements. 1.16: Drug treatments can now be stratified by dose and dosing type with the new 'treatment' functionality. Dose stratifications can be used in network meta-analyses and pairwise meta-analyses. Added hypertension example data set. Allow importing of results from clinicaltrials.gov (experimental). Fixed bugs which could lead to data loss. 1.14.1: Bugfix release. 1.14: Network meta-analysis results can now be saved in the ADDIS data file. In addition, the computations can be reset and there is a new visual progress indicator. 1.12.5: Bugfix release. 1.12.4: The network meta-analysis simulation can be continued if it has not converged yet, and there is a new GUI for checking convergence. The benefit-risk analysis now uses the full covariance information from network meta-analysis. Reduced download from 30MB to 15MB. Bugfixes. 1.12.3: Bugfix release. 1.12.2: Bugfix release. 1.12.1: Input name of analyses in the first step of the wizard, not in a pop-up dialog at the very end. 1.12: Add [BRAT table][10] and its value tree to benefit-risk view, allow selection of baseline in benefit-risk analysis, enable BRAT description of benefit-risk analysis, improve performance of network meta-analysis wizard, clarify error dialog with bug reporting instructions, fix many bugs. 1.10.1: Bugfix release 1.10: Enable combination treatment. Add "free text" ('Other') activity. Allow multiple moments of measurement for each outcome. Add installer and double-click loading of .addis data files on Windows. 1.8: Input study design (time structure), allow missing measurements, generate summary of efficacy table according to EMA D80 template, support of primary/secondary endpoints. 1.6.2: Bugfix release 1.6.1: Performance improvements for network meta-analysis, rank probability table. 1.6: User interface improvements, risk-based sampling in MetaBR, new schema-based XML format, added note taking in study wizard. 1.4: Lynd & O'Brien benefit-risk analysis, corrected meta-analysis, network meta-analysis enhancements (assessment of convergence, variance parameters, node-splitting analysis, R-dump of results, memory management), tabbed views. 1.2.1: Bugfix release 1.2: Benefit-risk models based on a single study. 1.0: Welcome screen, limited editing, links to various information systems (PubMed, medicines.org.uk, whocc.no) and many minor improvements. 0.10: Benefit-risk analysis, baseline effect (heuristic) estimation 0.8.1: Faster network meta-analysis (updated library), minor fixes 0.8: Network meta-analysis, XML import/export 0.6: Added add-study-wizard, import from ClinicalTrials.gov 0.4.1: Fixed example data (studies Org 022 and 023), changed domain to be version-specific. 0.4: Added meta-analysis, removed combined studies and MCDA-hookup. Lots of minor changes. 0.2: Initial release. Building ADDIS from source -------------------------- All releases as well as a nightly build (see [the DrugIS website][5]) are distributed in a compiled format. However, we also provide source for external development / verification. The sources can be checked out of the [ADDIS Git repository][6]. In order to compile ADDIS, you need: - Java >= 1.6 - [Maven 2][7] - Other dependencies should be downloaded automatically by Maven2 Building is automatic with "mvn package". Developing ADDIS using Eclipse ------------------------------ First, let Maven configure your workspace for use with Maven: $ mvn eclipse:configure-workspace -Declipse.workspace=WORKSPACE_DIR Use Maven to generate the eclipse project: $ cd SOURCE_DIR $ mvn eclipse:eclipse Then import the project into Eclipse (File -> Import -> Existing projects). License ------- ADDIS is open source, and licensed under [GPLv3][8]. See [LICENSE.txt][9] for more information. Contact ------- For contact information, see [the ADDIS website][1]. ADDIS Development Team [1]: http://www.drugis.org/addis [2]: http://www.tipharma.com/projects/efficiency-analysis-drug-discovery-process/the-escher-project.html [3]: http://pubmed.com/16172440 [4]: http://www.java.com/getjava/ [5]: http://www.drugis.org/ [6]: https://github.com/gertvv/addis [7]: http://maven.apache.org/download.html [8]: http://gplv3.fsf.org/ [9]: https://github.com/gertvv/addis/blob/master/LICENSE.txt [10]: http://dx.doi.org/10.1038/clpt.2010.291
本源码包内暂不包含可直接显示的源代码文件,请下载源码包。